Michael Evans, PhD, Awarded Major Grant from the Tuberous Sclerosis Complex Research Program of the Department of Defense’s Congressionally Directed Medical Research Program

Dr. Michael Evans was recently awarded a research grant that aims to develop new drugs to more effectively treat or eliminate tuberous sclerosis complex, or TSC. The research team has developed an innovative strategy that will allow them to screen for antibody fragments specific for cells lacking TSC1 or TSC2.